Angitia Biopharmaceuticals - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeAngitia Biopharmaceuticals
Angitia Biopharmaceuticals logo

Angitia Biopharmaceuticals

0 followers

About Angitia Biopharmaceuticals

Angitia Biopharmaceuticals is a clinical‑stage biotechnology company focused on discovering and developing innovative therapeutics for serious musculoskeletal diseases. The company is advancing three biologic product candidates in the clinic for osteoporosis, osteogenesis imperfecta, and spinal fusion, leveraging extensive scientific expertise in novel drug development. With a global outlook, Angitia aims to address key unmet medical needs in bone health and skeletal disorders.

Recent News

Recent Deals

Key Facts

HQ Location

Los Angeles, United States

Founded

2018

Employees

11 - 50

Status

Private

Website

https://angitiabio.com